CVS Caremark Program Offers Zero Cost Sharing For ‘Entire Range’ Of Diabetes Drugs
Executive Summary
Initiative aligns with IRS notice allowing high deductible health plans with health savings accounts to provide first dollar coverage for insulin and other glucose lowering agents before members have met their deductibles.
You may also be interested in...
Medicare’s Insulin Demo Project Likely Depends On Plan Interest
Manufacturers are on board for ‘Part D Senior Savings Model’ that would set a $35 copay cap, but added risk corridor payments may be the key to getting PBMs to offer the enhanced plans focused on reducing insulin costs for patients.
Lilly Adds Two More Humalog Authorized Generics As Insurance Deductibles Reset
With rebate reform efforts stalled, insulin manufacturer broadens efforts to lower prices through authorized generics, but PBMs may still like the big rebates they can get on the original brands.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.